Image from The Nation Thailand/ANN
BANGKOK, Nov 20 (Bernama): Thailand’s Chulalongkorn University is expected to start the production of its mRNA Covid-19 vaccine, ChulaCov19, in the first quarter of next year.
Head of the Covid-19 vaccine development project Dr Kiat Ruxrungtham said ChulaCov19 will enter its third phase of human trials, with jabs scheduled to be administered in the first quarter of 2022 as well.